The first health economics data from the Global Anticoagulant Registry in the Field – Atrial Fibrillation (GARFIELD-AF) was presented at ESC Congress 2017, organised by the European Society of Cardiology, in Barcelona, Spain.
Electrospun materials bring a spark of hope to a cardiovascular landscape darkened by setbacks for reabsorbable stents. It was famously said that implanting a device in a person to cure a disease is to implant a new disease. Simply put, the human body will continually fight against foreign materials, leading to chronic inflammations or repeated interventions.
Shielding cardiologists from harmful radiation is the goal for two systems capable of navigating the vascular highway.
Scientists in the United Kingdom are investigating the potential of a new regenerative and tissue engineering technique that could transform veins into arteries to improve the outcomes for patients undergoing heart bypass surgery.
An all-female satellite symposium during the Europace-Cardiostim Congress (EHRA 2017) in Vienna managed to turn quite a few heads. In the panel, the women discussed a very special alliance.
A new type of scan that can detect cardiac inflammation may help tailor treatment for patients who have suffered a heart attack, according to research findings presented at the British Cardiovascular Society (BCS) conference in June.
A Spanish team has, for the first time, successfully placed a pulmonary valve using catheterisation through the hepatic vein in a paediatric patient. Specialists believe this type of intervention could become an interesting alternative when traditional access points are not available.
Which CRT patients can be ‘downgraded’ from a CRT-D device with defibrillator function to a CRT-P with just a pacemaker function? This, with two further current CRT issues – chronotropic incompetence and telemonitoring of CRT patients – featured prominently at the Europace-Cardiostim Congress in Vienna.
Leading cardiologist and healthcare researcher Professor Harlan Krumholz has warned that medical practitioners must embrace the potential of digital data generated by patients if they are to avoid being left behind as the digital revolution moves forward at an ever-advancing pace
A pioneering study has certified that wearable technology produced better results in monitoring cardiac patients and improving their quality of life compared to conventional systems.
Over seven million people were using remote monitoring in 2016, mainly for cardiac rhythm management (CRM) and sleep apnoea therapy. The number of users will soar as they can increasingly connect to servers and clouds, Swedish analyst Anders Frick predicts.
A formerly bitter competition between cardiology and cardiac surgery is increasingly replaced by constructive cooperation. The Austrian Society of Cardiology (ÖKG) even held its annual congress along with the Austrian Society of Thoracic and Cardiovascular Surgery this year.
With 4,500 accepted abstracts, 600 sessions and 30,000 expected attendees, ESC Congress 2017 is undoubtedly the world’s largest cardiovascular event. On healthcare-in-europe.com, Dr Stephan Achenbach, Congress Program Committee Chairperson, gives an overview of issues and events unfolding in Barcelona from August 26-30.
Coronary angioplasty is arguably the most revolutionary breakthrough in the history of cardiology. While the technique is today performed on millions of patients worldwide, its origins can be traced back to Zurich, Switzerland, in the late 1970s.
Celebrating 40 years of PCI, cardiologists fret over their future with big data, machine learning and robots.
Researchers discover a new molecule, ‘Singheart’, that may hold the key to triggering the regeneration and repair of damaged heart cells.
Cardiac stem cell infusions could someday help reverse the aging process in the human heart, making older ones behave younger, according to a new study from the Cedars-Sinai Heart Institute.
Biotronik’s Home Monitoring is an award-winning remote cardiac monitoring system that automatically collects data from a patient’s cardiac device, enabling the physician to review cardiac function independently of in-office visits.
Cardiology in extreme environments takes centre stage at the British Cardiovascular Society (BCS) annual conference.
Professionals in the field of children’s cardiology will hold their world congress in FCB’s Camp Nou, Barcelona, Spain from the 16th to the 21st of July 2017. As part of the congress and for the first time, a special symposium will unite leading experts in the field of sports cardiology to discuss the heart health of the sports stars of the future.
Arteriogenesis is a critical event – not only during development but also in adult life. Many Cardiovascular life-threatening events could be overcome by inducing the formation of new arteries. A team of scientists led by Ralf Adams from the Max Planck Institute for Molecular Biomedicine has developed a genetic approach in mice to uncover molecular mechanisms of arterial growth.
The EASY PULSE® is an unbelievably small and light mechanical chest compression device. Performing manual chest compressions well for an extended period of time is almost impossible. Not only is it physically demanding, but other actions, such as vital signs monitoring, are also required simultaneously. SCHILLER’s EASY PULSE® is the solution for more efficient resuscitation: this portable,…
The ADVIA Centaur® High-Sensitivity Troponin I (TNIH) assay* is the latest addition to Siemens Healthineers’ comprehensive cardiac menu to assist clinicians with the diagnosis and treatment of chest pain patients. Designed to aid in diagnosing acute myocardial infarctions (AMI) through the quantitative measurement of cardiac troponin I in serum or plasma, high-sensitivity troponin plays a…
Breast implants may impede an electrocardiogram (ECG) and could result in a false heart attack diagnosis, according to research by the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC).
Researchers at the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR have engineered a three-dimensional heart tissue from human stem cells to test the safety and efficacy of new drugs on the heart.
